Deutsche Bank’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-740,882
| Closed | -$11.2M | – | 4131 |
|
|
2022
Q3 | $11.2M | Sell |
740,882
-262,561
| -26% | -$3.05M | 0.01% | 924 |
|
|
2022
Q2 | $7.53M | Buy |
1,003,443
+719,744
| +254% | +$5.07M | ﹤0.01% | 1115 |
|
|
2022
Q1 | $2.58M | Sell |
283,699
-22,085
| -7% | -$170K | ﹤0.01% | 1746 |
|
|
2021
Q4 | $2.15M | Sell |
305,784
-263,664
| -46% | -$2.76M | ﹤0.01% | 1946 |
|
|
2021
Q3 | $6.49M | Sell |
569,448
-76,240
| -12% | -$1.11M | ﹤0.01% | 1370 |
|
|
2021
Q2 | $10.3M | Sell |
645,688
-56,725
| -8% | -$973K | 0.01% | 1174 |
|
|
2021
Q1 | $12.6M | Buy |
702,413
+340,600
| +94% | +$5.88M | 0.01% | 1084 |
|
|
2020
Q4 | $4.89M | Buy |
361,813
+90,521
| +33% | +$1.09M | ﹤0.01% | 1376 |
|
|
2020
Q3 | $3.19M | Buy |
271,292
+156,897
| +137% | +$1.91M | ﹤0.01% | 1471 |
|
|
2020
Q2 | $1.69M | Buy |
114,395
+87,036
| +318% | +$1.29M | ﹤0.01% | 1900 |
|
|
2020
Q1 | $369K | Buy |
27,359
+4,700
| +21% | +$89.2K | ﹤0.01% | 2636 |
|
|
2019
Q4 | $546K | Sell |
22,659
-3,269
| -13% | -$67.7K | ﹤0.01% | 2675 |
|
|
2019
Q3 | $497K | Sell |
25,928
-138,920
| -84% | -$3.18M | ﹤0.01% | 2685 |
|
|
2019
Q2 | $4.87M | Buy |
164,848
+89,972
| +120% | +$3.47M | ﹤0.01% | 1829 |
|
|
2019
Q1 | $3.56M | Buy |
74,876
+35,951
| +92% | +$1.58M | ﹤0.01% | 2091 |
|
|
2018
Q4 | $1.4M | Sell |
38,925
-58,376
| -60% | -$2.74M | ﹤0.01% | 2645 |
|
|
2018
Q3 | $5.99M | Sell |
97,301
-103,871
| -52% | -$6.68M | ﹤0.01% | 2039 |
|
|
2018
Q2 | $13.6M | Buy |
201,172
+136,118
| +209% | +$7.62M | 0.01% | 1483 |
|
|
2018
Q1 | $3.53M | Sell |
65,054
-23,113
| -26% | -$1.29M | ﹤0.01% | 2484 |
|
|
2017
Q4 | $5.27M | Sell |
88,167
-9,483
| -10% | -$575K | ﹤0.01% | 1989 |
|
|
2017
Q3 | $4.74M | Sell |
97,650
-322,228
| -77% | -$17.6M | ﹤0.01% | 1946 |
|
|
2017
Q2 | $22.1M | Sell |
419,878
-272,281
| -39% | -$12.7M | 0.02% | 894 |
|
|
2017
Q1 | $31.4M | Sell |
692,159
-65,983
| -9% | -$2.94M | 0.02% | 688 |
|
|
2016
Q4 | $28.7M | Buy |
758,142
+750,765
| +10,177% | +$28.4M | 0.02% | 696 |
|
|
2016
Q3 | $277K | Sell |
7,377
-994
| -12% | -$21.9K | ﹤0.01% | 3481 |
|
|
2016
Q2 | $146K | Buy |
8,371
+27
| +0.3% | +$437 | ﹤0.01% | 3910 |
|
|
2016
Q1 | $100K | Sell |
8,344
-33,575
| -80% | -$531K | ﹤0.01% | 4011 |
|
|
2015
Q4 | $1.02M | Buy |
41,919
+421
| +1% | +$9.82K | ﹤0.01% | 2860 |
|
|
2015
Q3 | $734K | Buy |
41,498
+28,999
| +232% | +$525K | ﹤0.01% | 3131 |
|
|
2015
Q2 | $219K | Sell |
12,499
-58,147
| -82% | -$1.07M | ﹤0.01% | 3845 |
|
|
2015
Q1 | $2.21M | Buy |
70,646
+47,652
| +207% | +$1.38M | ﹤0.01% | 2365 |
|
|
2014
Q4 | $669K | Buy |
22,994
+12,731
| +124% | +$323K | ﹤0.01% | 3478 |
|
|
2014
Q3 | $212K | Buy |
10,263
+3,812
| +59% | +$75.2K | ﹤0.01% | 4034 |
|
|
2014
Q2 | $159K | Sell |
6,451
-462
| -7% | -$8K | ﹤0.01% | 4277 |
|
|
2014
Q1 | $146K | Sell |
6,913
-24,133
| -78% | -$488K | ﹤0.01% | 4066 |
|
|
2013
Q4 | $556K | Buy |
+31,046
| New | +$404K | ﹤0.01% | 3030 |
|
Deutsche Bank's AERI Position: Q4 2022 in Review
Deutsche Bank sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 740,882 shares — an estimated $11.2M sold.
Deutsche Bank first reported a position in AERI in Q4 2013 and held it in 36 quarters. The position peaked at $31.4M in Q1 2017. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Deutsche Bank reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Deutsche Bank sold 740,882 Aerie Pharmaceuticals shares in Q4 2022, an estimated $11.2M.
- Deutsche Bank first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 36 quarters.
- Deutsche Bank's Aerie Pharmaceuticals position peaked at $31.4M in Q1 2017.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Deutsche Bank's 13F filing for Q4 2022, filed 13 Feb 2023.